{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:00:19Z","timestamp":1787828419444,"version":"build-2784847793"},"reference-count":200,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.rdc.2006.05.010","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T10:09:23Z","timestamp":1168423763000},"page":"465-490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Cerebral Manifestations in the Antiphospholipid (Hughes) Syndrome"],"prefix":"10.1016","volume":"32","author":[{"given":"Giovanni","family":"Sanna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"D'Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jose","family":"Cuadrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rdc.2006.05.010_bib1","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop","volume":"42","author":"Wilson","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.05.010_bib2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rdc.2006.05.010_bib3","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.05.010_bib4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/08916930410001708706","article-title":"Antiphospholipid (Hughes) syndrome","volume":"37","author":"Khamashta","year":"2004","journal-title":"Autoimmunity"},{"key":"10.1016\/j.rdc.2006.05.010_bib5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1196\/annals.1361.088","article-title":"Hughes syndrome, the antiphospholipid syndrome: a new chapter in neurology","volume":"1051","author":"Sanna","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.rdc.2006.05.010_bib6","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/rheumatology\/keg080","article-title":"Central nervous system involvement in the antiphospholipid (Hughes) syndrome","volume":"42","author":"Sanna","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2006.05.010_bib7","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/bmj.287.6399.1088","article-title":"Thrombosis, abortion, cerebral disease and the lupus anticoagulant","volume":"287","author":"Hughes","year":"1983","journal-title":"BMJ"},{"key":"10.1016\/j.rdc.2006.05.010_bib8","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/S0140-6736(83)91113-3","article-title":"Antiphospholipid antibodies in acute Guillain-Barr\u00e9 syndrome","volume":"ii","author":"Harris","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.rdc.2006.05.010_bib9","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2230.1984.tb00856.x","article-title":"The Prosser-White oration 1983. Connective tissue disease and the skin","volume":"9","author":"Hughes","year":"1984","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.rdc.2006.05.010_bib10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/ard.44.4.281","article-title":"Lupoid sclerosis: a possible pathogenetic role for antiphospholipid antibodies","volume":"44","author":"Harris","year":"1985","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2006.05.010_bib11","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/ard.46.8.605","article-title":"Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies","volume":"46","author":"Asherson","year":"1987","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2006.05.010_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00005792-200001000-00006","article-title":"Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature","volume":"79","author":"Cuadrado","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rdc.2006.05.010_bib13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/qjmed\/94.2.114","article-title":"Migraine in Hughes syndrome. Heparin as a therapeutic trial?","volume":"94","author":"Cuadrado","year":"2001","journal-title":"Q J Med"},{"key":"10.1016\/j.rdc.2006.05.010_bib14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/pmj.79.928.81","article-title":"Migraine, memory loss, and \u201cmultiple sclerosis.\u201d Neurological features of the antiphospholipid (Hughes') syndrome","volume":"79","author":"Hughes","year":"2003","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.rdc.2006.05.010_bib15","first-page":"1344","article-title":"Features associated with epilepsy in the antiphospholipid syndrome","volume":"31","author":"Shoenfeld","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2006.05.010_bib16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/rheumatology\/keh408","article-title":"Dementia associated with the antiphospholipid syndrome: clinical and radiological characteristics of 30 patients","volume":"44","author":"Gomez-Puerta","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2006.05.010_bib17","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1055\/s-0038-1656365","article-title":"Antiphospholipid antibody positive sera enhance endothelial cell procoagulant activity\u2014studies in a thrombosis model","volume":"68","author":"Oosting","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rdc.2006.05.010_bib18","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1172\/JCI118276","article-title":"Activation of cultured vascular endothelial cells by antiphospholipid antibodies","volume":"96","author":"Simantov","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rdc.2006.05.010_bib19","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/art.1780400322","article-title":"Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-beta 2-glycoprotein I antibodies react in vitro with endothelial cells through adherent beta 2-glycoprotein I and induce endothelial activation","volume":"40","author":"Del Papa","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.05.010_bib20","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1191\/0961203303lu503oa","article-title":"Endothelium and the brain in CNS lupus","volume":"12","author":"Meroni","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2006.05.010_bib21","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1191\/0961203303lu504oa","article-title":"Cerebral haemostasis and antiphospholipid antibodies","volume":"12","author":"Connor","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2006.05.010_bib22","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/ard.51.6.707","article-title":"Inhibition of astrocyte proliferation and binding to brain tissue of anticardiolipin antibodies purified from lupus serum","volume":"51","author":"Sun","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2006.05.010_bib23","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2249.1991.tb05733.x","article-title":"A study of immune responses to myelin and cardiolipin in patients with systemic lupus erythematosus (SLE)","volume":"85","author":"Khalili","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.rdc.2006.05.010_bib24","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1191\/0961203303lu500oa","article-title":"CNS dysfunction in the antiphospholipid syndrome","volume":"12","author":"Katzav","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2006.05.010_bib25","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1191\/0961203303lu409oa","article-title":"Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer","volume":"12","author":"Shoenfeld","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2006.05.010_bib26","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1172\/JCI0212337","article-title":"Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome","volume":"109","author":"Blank","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rdc.2006.05.010_bib27","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1191\/0961203302lu255oa","article-title":"Behavioral and cognitive deficits occur only after prolonged exposure of mice to antiphospholipid antibodies","volume":"11","author":"Shrot","year":"2002","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2006.05.010_bib28","first-page":"67","article-title":"Neurological dysfunction associated with antiphospholipid syndrome: histopathological brain findings of thrombotic changes in a mouse model","volume":"11","author":"Ziporen","year":"2004","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.rdc.2006.05.010_bib29","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1001\/archinte.1997.00440390101013","article-title":"A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis","volume":"157","author":"Krnic-Barrie","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.rdc.2006.05.010_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1191\/096120398678919624","article-title":"Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients","volume":"7","author":"Shah","year":"1998","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2006.05.010_bib31","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1191\/0961203303lu496oa","article-title":"APS and the brain","volume":"12","author":"Sastre-Garriga","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2006.05.010_bib32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1191\/096120300680199015","article-title":"Cerebral blood flow and glucose metabolism in multi-infarct-dementia related to primary antiphospholipid antibody syndrome","volume":"9","author":"Hilker","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2006.05.010_bib33","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1159\/000085567","article-title":"Clinical characteristics of stroke patients with antiphospholipid antibodies","volume":"19","author":"Terashi","year":"2005","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.rdc.2006.05.010_bib34","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0002-9343(89)90335-5","article-title":"Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome","volume":"86","author":"Asherson","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.rdc.2006.05.010_bib35","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/ana.410230411","article-title":"Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura","volume":"23","author":"Devinsky","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1016\/j.rdc.2006.05.010_bib36","first-page":"350","article-title":"Thrombotic endocarditis and lupus anticoagulant. A pathogenetic possibility for idiopathic \u201crheumatic type\u201d valvular heart disease","volume":"113","author":"Ford","year":"1989","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.rdc.2006.05.010_bib37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0049-0172(97)80034-0","article-title":"Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features, and treatment","volume":"27","author":"Nesher","year":"1997","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.05.010_bib38","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/0140-6736(90)91373-I","article-title":"Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus","volume":"335","author":"Khamashta","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.rdc.2006.05.010_bib39","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/ard.2004.032813","article-title":"Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome","volume":"64","author":"Krause","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2006.05.010_bib40","first-page":"985","article-title":"Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies","volume":"30","author":"Sanna","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2006.05.010_bib41","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1212\/WNL.40.8.1190","article-title":"Antiphospholipid antibodies and cerebral ischemia in young people","volume":"40","author":"Brey","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.rdc.2006.05.010_bib42","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1212\/WNL.40.8.1181","article-title":"Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases","volume":"40","author":"Levine","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.rdc.2006.05.010_bib43","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1161\/01.STR.23.2.189","article-title":"Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischemia","volume":"23","author":"Nencini","year":"1992","journal-title":"Stroke"},{"key":"10.1016\/j.rdc.2006.05.010_bib44","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1212\/WNL.43.10.2069","article-title":"Anticardiolipin antibodies are an independent risk factor for first ischemic stroke","volume":"43","author":"The Antiphospholipid Antibodies in Stroke Study (APASS) Group","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.rdc.2006.05.010_bib45","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1600-0404.1995.tb00469.x","article-title":"Anticardiolipin antibodies in acute non-hemorrhagic stroke seen within six hours after onset","volume":"92","author":"Camerlingo","year":"1995","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.rdc.2006.05.010_bib46","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ana.410380119","article-title":"Recurrent stroke and thrombo-occlusive events in the antiphospholipid syndrome","volume":"38","author":"Levine","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.rdc.2006.05.010_bib47","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1161\/01.STR.30.8.1561","article-title":"Elevated anticardiolipin antibody titer is a stroke risk factor in a multiethnic population independent of isotype or degree of positivity","volume":"30","author":"Tuhrim","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.rdc.2006.05.010_bib48","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1080\/01616412.1999.11740992","article-title":"Anticardiolipin antibodies are an independent risk factor for ischemic stroke","volume":"21","author":"Zielinska","year":"1999","journal-title":"Neurol Res"},{"key":"10.1016\/j.rdc.2006.05.010_bib49","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1161\/01.STR.31.6.1283","article-title":"Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children","volume":"31","author":"Kenet","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.rdc.2006.05.010_bib50","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1161\/01.STR.32.8.1701","article-title":"beta(2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the Honolulu heart program","volume":"32","author":"Brey","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.rdc.2006.05.010_bib51","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1161\/01.STR.0000031927.25510.D1","article-title":"Antiphospholipid antibodies and stroke in young women","volume":"33","author":"Brey","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.rdc.2006.05.010_bib52","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/01.STR.0000117575.48205.2D","article-title":"Anticardiolipin antibodies and risk of ischemic stroke and transient ischemic attack: the Framingham cohort and offspring study","volume":"35","author":"Janardhan","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.rdc.2006.05.010_bib53","doi-asserted-by":"crossref","first-page":"997","DOI":"10.7326\/0003-4819-117-12-997","article-title":"Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis","volume":"117","author":"Ginsburg","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2006.05.010_bib54","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0140-6736(94)91775-2","article-title":"Anticardiolipin antibodies in an unselected stroke population","volume":"344","author":"Muir","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.rdc.2006.05.010_bib55","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1161\/01.STR.25.12.2412","article-title":"Value of immunologic testing in stroke patients. A prospective multicenter study","volume":"25","author":"Montalban","year":"1994","journal-title":"Stroke"},{"key":"10.1016\/j.rdc.2006.05.010_bib56","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1017\/S0317167100033515","article-title":"The frequency of phospholipid antibodies in an unselected stroke population","volume":"25","author":"Metz","year":"1998","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.rdc.2006.05.010_bib57","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1161\/01.STR.31.6.1289","article-title":"Anticardiolipin antibodies are not an independent risk factor for stroke: an incident case\u2013referent study nested within the MONICA and Vasterbotten cohort project","volume":"31","author":"Ahmed","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.rdc.2006.05.010_bib58","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1161\/01.STR.28.9.1660","article-title":"IgG anticardiolipin antibody titer >40 GPL and the risk of subsequent thrombo-occlusive events and death. A prospective cohort study","volume":"28","author":"Levine","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/j.rdc.2006.05.010_bib59","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1212\/WNL.48.1.91","article-title":"Anticardiolipin antibodies and the risk of recurrent thrombo-occlusive events and death","volume":"48","author":"The Antiphospholipid Antibodies and Stroke Study Group (APASS)","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.rdc.2006.05.010_bib60","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1001\/jama.291.5.576","article-title":"Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke","volume":"291","author":"Levine","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.rdc.2006.05.010_bib61","first-page":"2701","article-title":"Antiphospholipid antibodies and risk for recurrent vascular events","volume":"291","author":"Ruiz-Irastorza","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.rdc.2006.05.010_bib62","first-page":"2701","article-title":"Antiphospholipid antibodies and risk for recurrent vascular events","volume":"291","author":"Wahl","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.rdc.2006.05.010_bib63","first-page":"2701","article-title":"Antiphospholipid antibodies and risk for recurrent vascular events","volume":"291","author":"Cabral","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.rdc.2006.05.010_bib64","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/rheumatology\/keh666","article-title":"Stroke and antiphospholipid syndrome: the treatment debate","volume":"44","author":"Ruiz-Irastorza","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2006.05.010_bib65","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1182\/blood-2002-02-0441","article-title":"Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature","volume":"101","author":"Galli","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.rdc.2006.05.010_bib66","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1212\/WNL.62.2.194","article-title":"Increased anticardiolipin antibody IgG titers do not predict recurrent stroke or TIA in children","volume":"62","author":"Lanthier","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.rdc.2006.05.010_bib67","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1212\/01.WNL.0000055931.66009.D3","article-title":"Neuropathological findings in Sneddon's syndrome","volume":"60","author":"Hilton","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.rdc.2006.05.010_bib68","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2133.1965.tb14628.x","article-title":"Cerebro-vascular lesions and livedo reticularis","volume":"77","author":"Sneddon","year":"1965","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.rdc.2006.05.010_bib69","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1212\/WNL.38.5.798","article-title":"Sneddon's syndrome: an antiphospholipid antibody syndrome?","volume":"38","author":"Levine","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.rdc.2006.05.010_bib70","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-4362.1990.tb03755.x","article-title":"Cutaneous thrombosis, cerebrovascular thrombosis, and lupus anticoagulant\u2014the Sneddon syndrome. Report of 10 cases","volume":"29","author":"Alegre","year":"1990","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.rdc.2006.05.010_bib71","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/pmj.79.935.550","article-title":"Sneddon's syndrome: additional neurological feature in antiphospholipid (Hughes') syndrome","volume":"79","author":"Sinharay","year":"2003","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.rdc.2006.05.010_bib72","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1385\/CRIAI:25:1:61","article-title":"Unusual manifestations of the antiphospholipid syndrome","volume":"25","author":"Asherson","year":"2003","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.rdc.2006.05.010_bib73","first-page":"197","article-title":"Sneddon's syndrome: a cause of cognitive decline in young adults","volume":"14","author":"Adair","year":"2001","journal-title":"Neuropsychiatr Neuropsychol Behav Neurol"},{"key":"10.1016\/j.rdc.2006.05.010_bib74","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1006\/jaut.2000.0418","article-title":"The mystery of Sneddon syndrome: relationship with antiphospholipid syndrome and systemic lupus erythematosus","volume":"15","author":"Frances","year":"2000","journal-title":"J Autoimmun"},{"key":"10.1016\/j.rdc.2006.05.010_bib75","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1212\/WNL.40.3_Part_1.464","article-title":"Anticardiolipin antibodies in Sneddon's syndrome","volume":"40","author":"Kalashnikova","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.rdc.2006.05.010_bib76","first-page":"499","article-title":"Livedo reticularis is a marker for predicting multi-system thrombosis in antiphospholipid syndrome","volume":"23","author":"Toubi","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2006.05.010_bib77","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/ana.410250303","article-title":"Neurological disease associated with antiphospholipid antibodies","volume":"25","author":"Briley","year":"1989","journal-title":"Ann Neurol"},{"key":"10.1016\/j.rdc.2006.05.010_bib78","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1055\/s-2008-1071574","article-title":"Antiphospholipid antibodies in cerebrovascular ischemia and stroke in childhood","volume":"25","author":"Schoning","year":"1994","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.rdc.2006.05.010_bib79","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0887-8994(95)00218-9","article-title":"Antiphospholipid antibody syndrome in childhood strokes","volume":"13","author":"Takanashi","year":"1995","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.rdc.2006.05.010_bib80","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000028830","article-title":"Primary antiphospholipid syndrome with moyamoya-like vascular changes","volume":"31","author":"Booth","year":"1999","journal-title":"Pediatr Neurosurg"},{"key":"10.1016\/j.rdc.2006.05.010_bib81","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/archneur.56.8.967","article-title":"Prethrombotic disorders in children with arterial ischemic stroke and sinovenous thrombosis","volume":"56","author":"Bonduel","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.rdc.2006.05.010_bib82","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0887-8994(01)00367-8","article-title":"Moyamoya, dystonia during hyperventilation, and antiphospholipid antibodies","volume":"26","author":"Bakdash","year":"2002","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.rdc.2006.05.010_bib83","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.pediatrneurol.2004.05.015","article-title":"Noonan syndrome, moyamoya-like vascular changes, and antiphospholipid syndrome","volume":"31","author":"Yamashita","year":"2004","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.rdc.2006.05.010_bib84","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/01.STR.28.12.2363","article-title":"Cerebral venous thrombosis and anticardiolipin antibodies","volume":"28","author":"Carhuapoma","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/j.rdc.2006.05.010_bib85","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1161\/01.STR.18.4.801","article-title":"Cerebral venous thrombosis with lupus anticoagulants. Report of two cases","volume":"18","author":"Levine","year":"1987","journal-title":"Stroke"},{"key":"10.1016\/j.rdc.2006.05.010_bib86","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/00004728-199409000-00007","article-title":"Dural sinus thrombosis and venous infarction associated with antiphospholipid antibodies: MR findings","volume":"18","author":"Provenzale","year":"1994","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.rdc.2006.05.010_bib87","first-page":"92","article-title":"Venous dural sinus thrombosis in a middle-aged woman with anticardiolipin antibodies","volume":"95","author":"Camaiti","year":"1995","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.rdc.2006.05.010_bib88","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1161\/01.STR.26.7.1193","article-title":"Cerebral venous thrombosis in adults. A study of 40 cases from Saudi Arabia","volume":"26","author":"Daif","year":"1995","journal-title":"Stroke"},{"key":"10.1016\/j.rdc.2006.05.010_bib89","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/pgmj.71.838.487","article-title":"Cerebral venous sinus thrombosis and antiphospholipid antibodies","volume":"71","author":"Boggild","year":"1995","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.rdc.2006.05.010_bib90","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/01.STR.27.10.1724","article-title":"Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis","volume":"27","author":"Deschiens","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.rdc.2006.05.010_bib91","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/art.1780370418","article-title":"Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus","volume":"37","author":"Herranz","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.05.010_bib92","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0002-9343(99)80188-0","article-title":"Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus","volume":"99","author":"Toubi","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.rdc.2006.05.010_bib93","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0002-9343(97)90046-2","article-title":"Prevalence and signification of antinuclear and anticardiolipin antibodies in patients with epilepsy","volume":"103","author":"Verrot","year":"1997","journal-title":"Am J Med"},{"key":"10.1016\/j.rdc.2006.05.010_bib94","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1191\/096120301671577528","article-title":"Anti-cardiolipin and anti-beta2 glycoprotein I antibodies in Indian patients with systemic lupus erythematosus: association with the presence of seizures","volume":"10","author":"Shrivastava","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2006.05.010_bib95","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1053\/seiz.2001.0578","article-title":"Epilepsy associated with lupus anticoagulant","volume":"11","author":"Gibbs","year":"2002","journal-title":"Seizure"},{"key":"10.1016\/j.rdc.2006.05.010_bib96","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1212\/01.WNL.0000144178.32208.4F","article-title":"Epileptic seizures in systemic lupus erythematosus","volume":"63","author":"Appenzeller","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.rdc.2006.05.010_bib97","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/jnnp.48.2.185","article-title":"Epilepsy: an early symptom of systemic lupus erythematosus","volume":"48","author":"Mackworth-Young","year":"1985","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.rdc.2006.05.010_bib98","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-0404.1989.tb03721.x","article-title":"Lupus anticoagulant and the late onset seizures","volume":"79","author":"Inzelberg","year":"1989","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.rdc.2006.05.010_bib99","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/j.1528-1157.1999.tb02054.x","article-title":"Lupus anticoagulant induced by the combination of valproate and lamotrigine","volume":"40","author":"Echaniz-Laguna","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.rdc.2006.05.010_bib100","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0002-9343(00)00617-3","article-title":"Antiphospholipid and antinuclear antibodies in patients with epilepsy or new-onset seizure disorders","volume":"109","author":"Peltola","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.rdc.2006.05.010_bib101","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0920-1211(01)00273-X","article-title":"High prevalence of antiphospholipid antibodies in children with epilepsy: a controlled study of 50 cases","volume":"46","author":"Eriksson","year":"2001","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.rdc.2006.05.010_bib102","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.eplepsyres.2003.12.004","article-title":"Anticardiolipin and antinuclear antibodies in epilepsy\u2014a population-based cross-sectional study","volume":"58","author":"Ranua","year":"2004","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.rdc.2006.05.010_bib103","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1161\/01.STR.13.2.189","article-title":"Epileptic seizures in cerebral arterial occlusive disease","volume":"13","author":"Cocito","year":"1982","journal-title":"Stroke"},{"key":"10.1016\/j.rdc.2006.05.010_bib104","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/0024-3205(94)00422-6","article-title":"Anticardiolipin antisera from lupus patients with seizures reduce a GABA receptor-mediated chloride current in snail neurons","volume":"54","author":"Liou","year":"1994","journal-title":"Life Sci"},{"key":"10.1016\/j.rdc.2006.05.010_bib105","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1191\/096120399678847524","article-title":"Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes","volume":"8","author":"Chapman","year":"1999","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2006.05.010_bib106","first-page":"1725","article-title":"Monoclonal antiphosphatidylserine antibodies react directly with feline and murine central nervous system","volume":"24","author":"Kent","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2006.05.010_bib107","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1006\/exnr.2000.7358","article-title":"Ultrastructural localization of monoclonal antiphospholipid antibody binding to rat brain","volume":"163","author":"Kent","year":"2000","journal-title":"Exp Neurol"},{"key":"10.1016\/j.rdc.2006.05.010_bib108","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1177\/096120339600500412","article-title":"Elevated levels of anticardiolipin antibodies and epilepsy in lupus patients","volume":"5","author":"Liou","year":"1996","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2006.05.010_bib109","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/rheumatology\/keh384","article-title":"Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort","volume":"43","author":"Mikdashi","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2006.05.010_bib110","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0002-9343(00)00603-3","article-title":"Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus","volume":"109","author":"Karassa","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.rdc.2006.05.010_bib111","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/art.20957","article-title":"Electroencephalography in the assessment of neuropsychiatric manifestations in antiphospholipid syndrome and systemic lupus erythematosus","volume":"52","author":"Lampropoulos","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.05.010_bib112","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1191\/096120301678646119","article-title":"Sticky blood and headache","volume":"10","author":"Cuadrado","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2006.05.010_bib113","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1191\/0961203303lu506oa","article-title":"Headache and systemic lupus erythematosus","volume":"12","author":"Cuadrado","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2006.05.010_bib114","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1212\/WNL.42.3.681","article-title":"Lack of association between anticardiolipin antibodies and migraine in systemic lupus erythematosus","volume":"42","author":"Montalban","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.rdc.2006.05.010_bib115","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1212\/WNL.50.5.1433","article-title":"Role of anticardiolipin antibodies in young persons with migraine and transient focal neurologic events: a prospective study","volume":"50","author":"Tietjen","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.rdc.2006.05.010_bib116","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF00839210","article-title":"Migraine and headache in systemic lupus erythematosus and their relationship with antibodies against phospholipids","volume":"239","author":"Markus","year":"1992","journal-title":"J Neurol"},{"key":"10.1016\/j.rdc.2006.05.010_bib117","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1468-2982.1998.1804209.x","article-title":"Structural and neurochemical markers of brain injury in the migraine diathesis of systemic lupus erythematosus","volume":"18","author":"Rozell","year":"1998","journal-title":"Cephalalgia"},{"key":"10.1016\/j.rdc.2006.05.010_bib118","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1017\/S0317167100028183","article-title":"Lupus anticoagulant, antiphospholipid antibodies and migraine","volume":"15","author":"Hogan","year":"1988","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.rdc.2006.05.010_bib119","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1526-4610.1991.hed3110666.x","article-title":"Antiphospholipid antibodies in migraine","volume":"31","author":"Iniguez","year":"1991","journal-title":"Headache"},{"key":"10.1016\/j.rdc.2006.05.010_bib120","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1468-2982.1991.1101019.x","article-title":"Anticardiolipin antibodies in migraine","volume":"11","author":"Hering","year":"1991","journal-title":"Cephalalgia"},{"key":"10.1016\/j.rdc.2006.05.010_bib121","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1055\/s-0038-1651625","article-title":"Lack of association between antiphospholipid antibodies and migraine","volume":"69","author":"Tsakiris","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rdc.2006.05.010_bib122","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1526-4610.1991.hed3108537.x","article-title":"Migraine and anticardiolipin antibodies\u2014case reports of 13 patients, and the prevalence of antiphospholipid antibodies in migraineurs","volume":"31","author":"Robbins","year":"1991","journal-title":"Headache"},{"key":"10.1016\/j.rdc.2006.05.010_bib123","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s005990070023","article-title":"Lack of association between antiphospholipid antibodies and migraine in children","volume":"30","author":"Verrotti","year":"2000","journal-title":"Int J Clin Lab Res"},{"key":"10.1016\/j.rdc.2006.05.010_bib124","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0049-0172(87)90003-5","article-title":"Chorea in systemic lupus erythematosus and \u201clupus-like\u201d disease: association with antiphospholipid antibodies","volume":"16","author":"Asherson","year":"1987","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.05.010_bib125","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/ard.47.8.681","article-title":"Chorea in systemic lupus erythematosus: association with antiphospholipid antibodies","volume":"47","author":"Khamashta","year":"1988","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2006.05.010_bib126","first-page":"377","article-title":"Antiphospholipid antibodies and chorea","volume":"15","author":"Asherson","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2006.05.010_bib127","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00005792-199705000-00006","article-title":"Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature","volume":"76","author":"Cervera","year":"1997","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rdc.2006.05.010_bib128","first-page":"623","article-title":"Antiphospholipid syndrome and parkinsonism","volume":"16","author":"Milanov","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2006.05.010_bib129","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1353-8020(00)00025-0","article-title":"Antiphospholipid syndrome and dystonia-parkinsonism. A case report","volume":"7","author":"Milanov","year":"2001","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.rdc.2006.05.010_bib130","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1191\/0961203303lu242CR","article-title":"Primary antiphospholipid antibody syndrome masquerading as progressive supranuclear palsy","volume":"12","author":"Reiblat","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2006.05.010_bib131","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1353-8020(01)00031-1","article-title":"Antiphospholipid syndrome and dystonia-parkinsonism: need for anticoagulation","volume":"8","author":"Adhiyaman","year":"2002","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.rdc.2006.05.010_bib132","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1001\/archinte.1994.00420080127013","article-title":"Antiphospholipid antibody syndrome mimicking multiple sclerosis clinically and by magnetic resonance imaging","volume":"154","author":"Scott","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.rdc.2006.05.010_bib133","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1191\/096120399678847461","article-title":"Anti-phospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS?","volume":"8","author":"Ijdo","year":"1999","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2006.05.010_bib134","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1001\/archneur.55.4.517","article-title":"Systemic autoimmune features and multiple sclerosis: a 5-year follow-up study","volume":"55","author":"Tourbah","year":"1998","journal-title":"Arch Neurol"},{"key":"10.1016\/j.rdc.2006.05.010_bib135","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/ana.81","article-title":"Anticardiolipin antibodies are not a useful screening tool in a nonselected large group of patients with multiple sclerosis","volume":"49","author":"Sastre-Garriga","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.rdc.2006.05.010_bib136","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/jnnp.72.5.647","article-title":"Anticardiolipin antibodies in patients with multiple sclerosis do not represent a subgroup of patients according to clinical, familial, and biological characteristics","volume":"72","author":"Heinzlef","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.rdc.2006.05.010_bib137","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1600-0447.2005.00624.x","article-title":"Neuropsychiatric symptoms in patients with multiple sclerosis","volume":"112","author":"Figved","year":"2005","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.rdc.2006.05.010_bib138","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1176\/jnp.11.1.51","article-title":"Neuropsychiatric manifestations of multiple sclerosis","volume":"11","author":"Diaz-Olavarrieta","year":"1999","journal-title":"J Neuropsychiatr Clin Neurosci"},{"key":"10.1016\/j.rdc.2006.05.010_bib139","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1212\/WNL.55.1.51","article-title":"Quality of life as a predictor for change in disability in MS","volume":"55","author":"Nortvedt","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.rdc.2006.05.010_bib140","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/rheumatology\/keh532","article-title":"Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand?","volume":"44","author":"Ferreira","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2006.05.010_bib141","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/ard.2005.040352","article-title":"Evoked potential studies in the antiphospholipid syndrome: differential diagnosis from multiple sclerosis","volume":"65","author":"Paran","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2006.05.010_bib142","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s00296-003-0399-8","article-title":"Recurrent transverse myelitis in primary antiphospholipid syndrome\u2014case report and literature review","volume":"24","author":"Kim","year":"2004","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.rdc.2006.05.010_bib143","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00005792-198911000-00003","article-title":"Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients","volume":"68","author":"Alarcon-Segovia","year":"1989","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rdc.2006.05.010_bib144","first-page":"34","article-title":"Transverse myelitis: a manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies","volume":"17","author":"Lavalle","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2006.05.010_bib145","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/ard.59.2.120","article-title":"Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature","volume":"59","author":"Kovacs","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2006.05.010_bib146","first-page":"280","article-title":"Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies","volume":"31","author":"D'Cruz","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2006.05.010_bib147","first-page":"1085","article-title":"Primary antiphospholipid syndrome: a report of two pediatric cases","volume":"18","author":"Falcini","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2006.05.010_bib148","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1177\/096120339500400417","article-title":"Benign intracranial hypertension: a non-thrombotic complication of the primary antiphospholipid syndrome?","volume":"4","author":"Orefice","year":"1995","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2006.05.010_bib149","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1136\/jnnp.62.3.229","article-title":"Potentially prothrombotic abnormalities of coagulation in benign intracranial hypertension","volume":"62","author":"Sussman","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.rdc.2006.05.010_bib150","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/archneur.55.6.817","article-title":"Anticardiolipin antibodies are frequently present in patients with idiopathic intracranial hypertension","volume":"55","author":"Leker","year":"1998","journal-title":"Arch Neurol"},{"key":"10.1016\/j.rdc.2006.05.010_bib151","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1136\/jnnp.68.3.379","article-title":"Idiopathic intracranial hypertension and anticardiolipin antibodies","volume":"68","author":"Kesler","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.rdc.2006.05.010_bib152","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0196-0709(93)90075-I","article-title":"Anticardiolipin antibody-induced sudden profound sensorineural hearing loss","volume":"14","author":"Hisashi","year":"1993","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.rdc.2006.05.010_bib153","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF02214943","article-title":"Cogan's syndrome: a new possible complication of antiphospholipid antibodies?","volume":"14","author":"Casoli","year":"1995","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.rdc.2006.05.010_bib154","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0196-0709(95)90109-4","article-title":"Sudden sensorineural hearing loss and anticardiolipin antibody","volume":"16","author":"Tumiati","year":"1995","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.rdc.2006.05.010_bib155","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1177\/096120339700600611","article-title":"Autoimmune aberration in sudden sensorineural hearing loss: association with anti-cardiolipin antibodies","volume":"6","author":"Toubi","year":"1997","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2006.05.010_bib156","first-page":"589","article-title":"Sudden sensorineural hearing loss in patients with systemic lupus erythematosus or lupus-like syndromes and antiphospholipid antibodies","volume":"25","author":"Naarendorp","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2006.05.010_bib157","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s100670170069","article-title":"Sudden sensorineural hearing loss as a first manifestation of systemic lupus erythematosus: association with anticardiolipin antibodies","volume":"20","author":"Green","year":"2001","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.rdc.2006.05.010_bib158","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/08916939309010644","article-title":"Autoantibodies to phospholipids and brain extract in patients with the Guillain-Barre syndrome: cross-reactive or pathogenic?","volume":"16","author":"Gilburd","year":"1993","journal-title":"Autoimmunity"},{"key":"10.1016\/j.rdc.2006.05.010_bib159","first-page":"85","article-title":"Transient global amnesia and antiphospholipid syndrome","volume":"7","author":"Montalban","year":"1989","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2006.05.010_bib160","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0889-857X(21)00209-X","article-title":"Neurologic complications of antiphospholipid antibodies","volume":"19","author":"Brey","year":"1993","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.rdc.2006.05.010_bib161","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0039-6257(02)00289-8","article-title":"Primary anti-phospholipid antibody syndrome (APS): current concepts","volume":"47","author":"Durrani","year":"2002","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.rdc.2006.05.010_bib162","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/BF02247807","article-title":"Optic neuropathy in the \u201cprimary\u201d antiphospholipid syndrome: report of a case and review of the literature","volume":"16","author":"Reino","year":"1997","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.rdc.2006.05.010_bib163","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1076\/ocii.6.4.269.4025","article-title":"The clinical-ophtalmological spectrum of antiphospholipid syndrome","volume":"6","author":"Giorgi","year":"1998","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.rdc.2006.05.010_bib164","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0002-9394(03)00156-9","article-title":"Autoimmune optic neuropathy with anticardiolipin antibody mimicking multiple sclerosis in a child","volume":"136","author":"Frohman","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.rdc.2006.05.010_bib165","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/jnnp.73.4.429","article-title":"Optic neuromyelitis syndrome in Brazilian patients","volume":"73","author":"Papais-Alvarenga","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.rdc.2006.05.010_bib166","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0002-9394(14)71142-0","article-title":"Primary antiphospholipid antibody syndrome and retinal occlusive vasculopathy","volume":"123","author":"Wiechens","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.rdc.2006.05.010_bib167","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1442-9071.2004.00766.x","article-title":"Review of severe vaso-occlusive retinopathy in systemic lupus erythematosus and the antiphospholipid syndrome: associations, visual outcomes, complications and treatment","volume":"32","author":"Au","year":"2004","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.rdc.2006.05.010_bib168","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1136\/ard.62.7.687","article-title":"Anticardiolipin antibodies in acute multifocal posterior placoid pigment epitheliopathy","volume":"62","author":"Uthman","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2006.05.010_bib169","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.57.3.496","article-title":"The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus","volume":"57","author":"Ainiala","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.rdc.2006.05.010_bib170","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1212\/WNL.58.8.1214","article-title":"Neuropsychiatric syndromes in lupus: prevalence using standardized definitions","volume":"58","author":"Brey","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.rdc.2006.05.010_bib171","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1076\/jcen.25.1.145.13621","article-title":"Cognitive impairment in systemic lupus erythematosus and neuropsychiatric systemic lupus erythematosus: a population-based neuropsychological study","volume":"25","author":"Loukkola","year":"2003","journal-title":"J Clin Exp Neuropsychol"},{"key":"10.1016\/j.rdc.2006.05.010_bib172","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1212\/01.WNL.0000058904.94330.A7","article-title":"Neuropsychiatric lupus syndromes: relationship with antiphospholipid antibodies","volume":"61","author":"Afeltra","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.rdc.2006.05.010_bib173","first-page":"2156","article-title":"Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance","volume":"31","author":"Hanly","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2006.05.010_bib174","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/rheumatology\/32.4.291","article-title":"Cognitive impairment and autoantibodies in systemic lupus erythematosus","volume":"32","author":"Hanly","year":"1993","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.rdc.2006.05.010_bib175","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1017\/S1355617797003779","article-title":"The relationship of antiphospholipid antibodies to cognitive function in patients with systemic lupus erythematosus","volume":"3","author":"Denburg","year":"1997","journal-title":"J Int Neuropsychol Soc"},{"issue":"4","key":"10.1016\/j.rdc.2006.05.010_bib176","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/1529-0131(199904)42:4<728::AID-ANR16>3.0.CO;2-O","article-title":"A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus","volume":"42","author":"Hanly","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.05.010_bib177","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/1529-0131(199904)42:4<735::AID-ANR17>3.0.CO;2-L","article-title":"A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus","volume":"42","author":"Menon","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.05.010_bib178","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1006\/jaut.1998.0214","article-title":"Serum anti-beta2-glycoprotein I antibodies from patients with antiphospholipid antibody syndrome bind central nervous system cells","volume":"11","author":"Caronti","year":"1998","journal-title":"J Autoimmun"},{"key":"10.1016\/j.rdc.2006.05.010_bib179","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1191\/096120301678416060","article-title":"Hyperactivity in a mouse model of the antiphospholipid syndrome","volume":"10","author":"Katzav","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2006.05.010_bib180","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1177\/096120330101001103","article-title":"Headache and memory loss: rapid response to heparin in the antiphospholipid syndrome","volume":"10","author":"Hughes","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2006.05.010_bib181","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1161\/01.STR.20.2.225","article-title":"Lupus anticoagulants, anticardiolipin antibodies, and cerebral ischemia","volume":"20","author":"Kushner","year":"1989","journal-title":"Stroke"},{"key":"10.1016\/j.rdc.2006.05.010_bib182","first-page":"424","article-title":"Multi-infarct dementia associated with antiphospholipid antibodies. Presentation of 2 cases","volume":"93","author":"Montalban","year":"1989","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.rdc.2006.05.010_bib183","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2169\/internalmedicine.33.373","article-title":"A young case with multi-infarct dementia associated with lupus anticoagulant","volume":"33","author":"Kurita","year":"1994","journal-title":"Intern Med"},{"key":"10.1016\/j.rdc.2006.05.010_bib184","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000017211","article-title":"Dementia and antiphospholipid antibodies","volume":"11","author":"Mosek","year":"2000","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.rdc.2006.05.010_bib185","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0022-510X(02)00271-X","article-title":"Prevalence and clinical features of dementia associated with the antiphospholipid syndrome and circulating anticoagulants","volume":"203\u2013204","author":"Chapman","year":"2002","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.rdc.2006.05.010_bib186","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4088\/JCP.v59n0105","article-title":"High association of anticardiolipin antibodies with psychosis","volume":"59","author":"Schwartz","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.rdc.2006.05.010_bib187","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1191\/0961203303lu507oa","article-title":"A psychiatric perspective on the therapy of psychosis in systemic lupus erythematosus","volume":"12","author":"Bodani","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2006.05.010_bib188","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1191\/096120300678828695","article-title":"Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations","volume":"9","author":"Sanna","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2006.05.010_bib189","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/01.STR.0000052631.98405.15","article-title":"Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study","volume":"34","author":"Vermeer","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.rdc.2006.05.010_bib190","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa022066","article-title":"Silent brain infarcts and the risk of dementia and cognitive decline","volume":"348","author":"Vermeer","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2006.05.010_bib191","doi-asserted-by":"crossref","first-page":"R38","DOI":"10.1186\/ar1892","article-title":"Association between microscopic brain damage as indicated by magnetization transfer imaging and anticardiolipin antibodies in neuropsychiatric lupus","volume":"8","author":"Steens","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.rdc.2006.05.010_bib192","first-page":"1446","article-title":"Evaluation of regional cerebral blood flow with 99mTc-HMPAO in primary antiphospholipid antibody syndrome","volume":"40","author":"Kao","year":"1999","journal-title":"J Nucl Med"},{"key":"10.1016\/j.rdc.2006.05.010_bib193","first-page":"17","article-title":"Technetium-99mTc-HMPAO brain SPECT in antiphospholipid syndrome\u2014preliminary data","volume":"3","author":"Romanowicz","year":"2000","journal-title":"Nucl Med Rev Cent East Eur"},{"key":"10.1016\/j.rdc.2006.05.010_bib194","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1007\/s003300100841","article-title":"Technetium-99m-ECD SPECT in antiphospholipid antibody syndrome: a drastic improvement in brain perfusion by antiplatelet therapy","volume":"11","author":"Tokumaru","year":"2001","journal-title":"Eur Radiol"},{"key":"10.1016\/j.rdc.2006.05.010_bib195","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/03009740252937603","article-title":"Abnormal regional cerebral blood flow in primary antiphospholipid antibody syndrome patients with normal magnetic resonance imaging findings. A preliminary report","volume":"31","author":"Chen","year":"2002","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.rdc.2006.05.010_bib196","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00296-003-0314-3","article-title":"Using 99mTc HMPAO brain SPECT to evaluate the effects of anticoagulant therapy on regional cerebral blood flow in primary antiphospholipid antibody syndrome patients with brain involvement\u2014a preliminary report","volume":"23","author":"Sun","year":"2003","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.rdc.2006.05.010_bib197","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1191\/0961203303lu505oa","article-title":"Central nervous system lupus: a clinical approach to therapy","volume":"12","author":"Sanna","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2006.05.010_bib198","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJM199504133321504","article-title":"The management of thrombosis in the antiphospholipid-antibody syndrome","volume":"332","author":"Khamashta","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2006.05.010_bib199","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1001\/archinte.162.10.1164","article-title":"Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5","volume":"162","author":"Ruiz-Irastorza","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.rdc.2006.05.010_bib200","first-page":"S364","article-title":"Double blind, crossover, randomised trial comparing low molecular weight heparin versus placebo in the treatment of chronic headache in patients with antiphospholipid antibodies","volume":"48","author":"Cuadrado","year":"2003","journal-title":"Arthritis Rheum"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X06000512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X06000512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:04:49Z","timestamp":1760180689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X06000512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":200,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0889857X06000512"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2006.05.010","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebral Manifestations in the Antiphospholipid (Hughes) Syndrome","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2006.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}